HELIOS-A: IMPACT OF VUTRISIRAN ON QUALITY OF LIFE AND FUNCTIONAL STATUS IN HEREDITARY TRANSTHYRETIN-MEDIATED AMYLOIDOSIS

被引：0
|
作者：
Ajroud-Driss, Senda [1 ]
Berk, John L. [2 ]
Adams, David [3 ,4 ]
Gillmore, Julian [5 ]
Lin, Kon-Ping [6 ]
Kale, Parag [7 ]
Koike, Haruki [8 ]
Aldinc, Emre [9 ]
Chen, Chongshu [9 ]
Vest, John [9 ]
Obici, Laura [10 ]
机构：
[1] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Neurol, Chicago, IL 60611 USA
[2] Boston Med Ctr, Boston, MA USA
[3] Univ Paris Saclay, INSERM, U1195, Le Kremlin Bicetre, France
[4] CHU Bicetre, AP HP, Neurol Dept, Le Kremlin Bicetre, France
[5] UCL, Royal Free Hosp, Natl Amyloidosis Ctr, London, England
[6] Taipei Vet Gen Hosp, Dept Neurol, Taipei, Taiwan
[7] Baylor Univ, Med Ctr, Dallas, TX USA
[8] Nagoya Univ, Dept Neurol, Grad Sch Med, Nagoya, Aichi, Japan
[9] Alnylam Pharmaceut, Cambridge, MA USA
[10] IRCCS Fdn Policlin San Matteo, Amyloidosis Res & Treatment Ctr, Pavia, Italy
来源：
JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S40 / S41
页数：2
相关论文
共 50 条
  • [41] Longitudinal changes in mNIS+7 are associated with changes in ambulatory status in hereditary transthyretin-mediated amyloidosis
    Coelho, Teresa
    Suhr, Ole
    Quan, Dianna
    Brannagan, Thomas
    Gollob, Jared
    Goyal, Sunita
    Altincatal, Arman
    Agarwal, Sonalee
    Lin, Hollis
    Adams, David
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2018, 23 (04) : 354 - 355
  • [42] Practical Guidance for the Use of Patisiran in the Management of Polyneuropathy in Hereditary Transthyretin-Mediated Amyloidosis
    Dixon, Stacy
    Kang, Xuan
    Quan, Dianna
    THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2023, 19 : 973 - 981
  • [43] Treatment with patisiran of a patient with hereditary transthyretin-mediated amyloidosis with stage 3 polyneuropathy
    Mueschen, Lars H.
    Koerner, Gudrun
    Gingele, Stefan
    Haenselmann, Anja
    Bavendiek, Udo
    Skripuletz, Thomas
    MUSCLE & NERVE, 2021, 64 (03) : E11 - E13
  • [44] Burden of hereditary transthyretin amyloidosis on quality of life
    Yarlas, Aaron
    Gertz, Morie A.
    Dasgupta, Noel R.
    Obici, Laura
    Pollock, Michael
    Ackermann, Elizabeth J.
    Lovley, Andrew
    Kessler, Asia Sikora
    Patel, Pankaj A.
    White, Michelle K.
    Guthrie, Spencer D.
    MUSCLE & NERVE, 2019, 60 (02) : 169 - 175
  • [45] Neurofilament light chain may serve as a biomarker in hereditary transthyretin-mediated amyloidosis
    Ticau, Simina
    Sridharan, Gautham
    Tsour, Shira
    Cantley, William
    Chan, Amy
    Gilbert, Jason
    Erbe, David
    Fitzgerald, Kevin
    Vaishnaw, Akshay
    Aldinc, Emre
    Nioi, Paul
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2020, 25 (04) : 530 - 531
  • [46] Impact of baseline neuropathy stage in patients with hereditary transthyretin-mediated (hATTR) amyloidosis with or without patisiran treatment
    Kyriakides, T.
    Brannagan, T.
    Lin, H.
    Wang, Y.
    Conceicao, I.
    EUROPEAN JOURNAL OF NEUROLOGY, 2019, 26 : 190 - 190
  • [47] Impact of vutrisiran on outpatient worsening heart failure in patients with transthyretin amyloidosis with cardiomyopathy in the HELIOS-B trial
    Fontana, Marianna
    Maurer, Mathew
    Gillmore, Julian
    Bender, Shaun
    Aldinc, Emre
    Eraly, Satish
    Jay, Patrick
    Solomon, Scott
    CIRCULATION, 2024, 150 (25) : E740 - E741
  • [48] Neurofilament light chain (NfL) as a potential biomarker in hereditary transthyretin-mediated (hATTR) amyloidosis
    Ticau, Simina
    Sridharan, Gautham
    Tsour, Shira
    Cantley, William
    Vaishnaw, Akshay
    Nioi, Paul
    JOURNAL OF THE PERIPHERAL NERVOUS SYSTEM, 2020, 25 : S13 - S13
  • [49] Indirect treatment comparison of the efficacy of patisiran and inotersen for hereditary transthyretin-mediated amyloidosis with polyneuropathy
    Gorevic, Peter
    Franklin, Jaclyn
    Chen, Jihong
    Sajeev, Gautam
    Wang, Jessie C. H.
    Lin, Hollis
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (01) : 121 - 129
  • [50] Expert opinion on monitoring symptomatic hereditary transthyretin-mediated amyloidosis and assessment of disease progression
    Adams, David
    Algalarrondo, Vincent
    Polydefkis, Michael
    Sarswat, Nitasha
    Slama, Michel S.
    Nativi-Nicolau, Jose
    ORPHANET JOURNAL OF RARE DISEASES, 2021, 16 (01)
12345